BMX-001
Sponsors
BioMimetix JV, LLC, University of Nebraska
Conditions
Anal Cancer, Squamous Cell CarcinomaAstrocytoma, Grade IIIEndometrial Cancer, Endometrial NeoplasmGlioblastomaHead and Neck CancerHigh Grade GliomaMultiple Brain MetastasesOvarian Neoplasms
Phase 1
Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001
CompletedNCT02655601
Start: 2018-09-25End: 2024-12-31Updated: 2025-06-08
A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer
CompletedNCT02990468
Start: 2017-04-19End: 2022-03-31Updated: 2023-03-15
Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer
Active, not recruitingNCT03386500
Start: 2017-11-28End: 2029-12-01Updated: 2026-01-26
A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy
TerminatedNCT03608020
Start: 2018-10-04End: 2024-04-15Updated: 2024-04-18
BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer
Not yet recruitingNCT06620029
Start: 2025-04-01End: 2027-07-31Target: 27Updated: 2024-10-01
Phase 2
Trial of BMX-001 or Placebo in Head and Neck Cancer Patients
WithdrawnNCT04607642
Start: 2021-07-31End: 2025-07-31Updated: 2021-10-11
Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001
RecruitingNCT05254327
Start: 2022-08-15End: 2029-06-30Target: 118Updated: 2025-08-07